🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to measure how much of the study drug get...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-08-13
Trial ID
NCT04991766
Treatments Being Tested
The main purpose of this study is to learn more about the safety, side effe...
Status
Recruiting
Location
Mayo Clinic of Scottsdale
Start Date
2022-05-11
Trial ID
NCT05307705
Treatments Being Tested
This is a study of LY3484356 in Chinese participants with advanced breast c...
Status
Active Not Recruiting
Location
Wannan Medical College Yijishan Hospital
Start Date
2022-10-09
Trial ID
NCT05509790
Treatments Being Tested
The main purpose of this study is to measure how much of Imlunestrant (LY34...
Status
Completed
Location
Inland Empire Liver Foundation
Start Date
2022-07-05
Trial ID
NCT05440344
Treatments Being Tested
The main purpose of this study is to evaluate the effect of imlunestrant (L...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2022-09-12
Trial ID
NCT05509816
Treatments Being Tested
The main purpose of this study is to evaluate the effect of imlunestrant on...
Status
Completed
Location
Altasciences Clinical Los Angeles, Inc
Start Date
2022-07-07
Trial ID
NCT05444556
Treatments Being Tested
This study will include two groups of patients: Cohort 1 and Cohort 2. Coh...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2026-05-13
Trial ID
NCT07287098
Treatments Being Tested
This phase II trial studies how well imlunestrant and abemaciclib work in t...
Status
Recruiting
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2026-05-18
Trial ID
NCT07191717
The purpose for this study is to see if the study drug, LY3484356, is safe ...
Status
Completed
Location
Winship Cancer Center Emory University
Start Date
2021-04-21
Trial ID
NCT04647487
Treatments Being Tested
The main purpose of this study is to evaluate the amount of LY3484356 that ...
Status
Completed
Location
LabCorp CRU, Inc.
Start Date
2021-04-26
Trial ID
NCT04840888
Treatments Being Tested